Filing Flows › Abbott Laboratories (ABT) › Net income
Abbott Laboratories (ABT) net income by quarter
Abbott Laboratories' net income was $920M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026. Over the last 7 quarters it ranged from $920M (Q3 2026) to $1.8B (Q2 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $920M | -0.9% | -44% |
| Q2 2026 | $928M | -14% | -48% |
| Q1 2026 | $1.1B | -39% | -19% |
| Q4 2025 | $1.8B | +8% | — |
| Q3 2025 | $1.6B | -8% | — |
| Q2 2025 | $1.8B | +34% | — |
| Q1 2025 | $1.3B | — | — |
Q3 2026 at a glance
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Abbott Laboratories' net income?
Abbott Laboratories' net income was $920M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026.
How has Abbott Laboratories' net income changed?
Over the last 7 quarters it ranged from $920M (Q3 2026) to $1.8B (Q2 2025).